IL1A and acute myeloid leukemia: Continuous exposure to IL-1, in association with IL-6, TNF (tumor necrosis factor) and IFNs (interferons), may promote genomic instability and induce a pre-leukemic stage via continuous proliferation, bone marrow niche dysfunction and exposure to reactive oxygen species (ROS), that drive myeloid malignancies such AML (54).